We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 90

What's in a name? Geographical indications under CETA
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • December 24 2014

Marketers of food products, take note: a swath of European locales will soon be restricted from being used in certain food product names. The new


CIPO-EPO PPH pilot programme set to begin in January 2015
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • December 10 2014

In another step towards building stronger bilateral relations and fast tracking the examination of counterpart patent applications, the Canadian


Le programme pilote d’ATDB entre l’OPIC et l’OEB débutera en janvier 2015
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • November 4 2014

Dans le cadre d’une nouvelle mesure visant à consolider les relations bilatérales et à accélérer le processus d’examen de demandes de brevets


CIPO-EPO PPH pilot program set to begin in January 2015
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • October 31 2014

In another step towards building stronger bilateral relations and fast-tracking the examination of counterpart patent applications, the Canadian


Get set for CETA
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • October 31 2014

A comprehensive trade deal has been agreed by the EU and Canada following five years of negotiations. CETA aims to further open EU and Canadian


Canada and the EU end CETA negotiations
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • October 31 2014

The consolidated text of the EU-Canada Comprehensive Economic and Trade Agreement (CETA) was officially published by both Canada and the EU on Sept


Personalized medicine: patent issues in Canada and Europe
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • October 16 2014

Canada Introduction 'Personalized medicine', in its broadest aspects, is essentially the tailoring of treatments to individual characteristics, needs


Canada and the EU sign CETA
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • October 3 2014

The consolidated text of the EU-Canada Comprehensive Economic and Trade Agreement (CETA) was officially signed and published by both Canada and the


CETA what does it mean for IP in Canada?
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • October 2 2014

Almost a year following an agreement-in-principle between Canada and the European Union, the official full text of the Canada-European Union


Personalized medicine: patent issues in Canada and Europe
  • Gowling Lafleur Henderson LLP
  • Canada, European Union
  • June 19 2014

"Personalized medicine," in its broadest aspects, is essentially the tailoring of treatments to individual characteristics, needs and preferences